11/14
11:31 am
anip
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? [Yahoo! Finance]
Low
Report
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? [Yahoo! Finance]
11/11
10:22 am
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.
Medium
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.
11/9
04:11 am
anip
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
11/8
11:57 am
anip
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
11/8
07:08 am
anip
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance [Yahoo! Finance]
Medium
Report
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance [Yahoo! Finance]
11/8
06:50 am
anip
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
Medium
Report
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
11/7
07:18 am
anip
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
11/4
04:45 pm
anip
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November [Yahoo! Finance]
11/4
04:30 pm
anip
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
Low
Report
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
10/30
05:00 pm
anip
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET
Low
Report
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET
10/25
06:50 am
anip
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
Low
Report
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
10/24
07:04 am
anip
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
10/24
06:50 am
anip
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
Low
Report
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
10/22
01:39 pm
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Truist Financial Co. from $60.00 to $62.00. They now have a "hold" rating on the stock.
Low
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Truist Financial Co. from $60.00 to $62.00. They now have a "hold" rating on the stock.
10/21
11:35 am
anip
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
10/17
01:23 pm
anip
GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review [Yahoo! Finance]
Low
Report
GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review [Yahoo! Finance]
10/17
07:32 am
anip
ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? [Yahoo! Finance]
10/15
01:45 pm
anip
Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]
Low
Report
Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report? [Yahoo! Finance]
10/11
01:48 pm
anip
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential [Yahoo! Finance]
10/11
08:07 am
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $68.00 price target on the stock.
Medium
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $68.00 price target on the stock.
10/9
11:49 am
anip
Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know [Yahoo! Finance]
Low
Report
Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know [Yahoo! Finance]
10/1
11:29 am
anip
MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine [Yahoo! Finance]
Low
Report
MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine [Yahoo! Finance]
9/30
01:13 pm
anip
AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V [Yahoo! Finance]
Low
Report
AbbVie Seeks Approval for Lung Cancer Candidate Teliso-V [Yahoo! Finance]
9/26
06:50 am
anip
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
Low
Report
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
9/18
02:07 pm
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Raymond James from $81.00 to $83.00. They now have an "outperform" rating on the stock.
Low
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Raymond James from $81.00 to $83.00. They now have an "outperform" rating on the stock.